Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosuppressive agents in Thyroid Associated Ophthalmopathy
NCT05110040Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2021
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Open-label trial in thyroid associated ophthalmopathy (TAO), sponsored by Sun Yat-sen University. Primary endpoint: Change of macular sensibility at 6 months. Started Oct 2021; status: recruiting.
02
Conditions
thyroid associated ophthalmopathy (TAO)
Beyond the preview
Go deeper on NCT05110040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110040.